Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...
MUNICH, Germany I January 30, 2025 I Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced ...